These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25488798)

  • 1. In Silico comparison between metoprolol succinate and bisoprolol on 24-hour systolic blood pressures.
    Jansson SO; Malm AE; Lundström T
    Drugs R D; 2014 Dec; 14(4):325-32. PubMed ID: 25488798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of bisoprolol to a metoprolol CR/ZOK tablet for control of heart rate and blood pressure in mild-to-moderate hypertensive patients: the CREATIVE study.
    Yang T; Jiang Y; Hao Y; Zhou S; Xu X; Qu B; Lin X; Ma T
    Hypertens Res; 2017 Jan; 40(1):79-86. PubMed ID: 27534738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL; Clissold SP
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.
    Lücker P; Moore G; Wieselgren I; Olofsson B; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S17-27. PubMed ID: 2312775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Casual versus ambulatory twenty-four-hour blood pressure measurement in a comparative study with bisoprolol or nitrendipine.
    Mengden T; Schubert M; Jeck T; Edmonds D; Vetter W
    J Hypertens Suppl; 1990 Sep; 8(4):S91-4. PubMed ID: 1979615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the trough-to-peak ratio of cardio-selective beta-blockers in patients with newly diagnosed hypertension.
    Soucek M; Rihacek I; Frana P
    Blood Press Monit; 2006 Dec; 11(6):337-42. PubMed ID: 17106318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
    Kukes VG; Ostroumova OD; Mamaev VI; Batutina AM; Abakumov IuE; Zykova AA
    Ter Arkh; 2003; 75(8):43-7. PubMed ID: 14520850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers.
    Deroubaix X; Lins RL; Lens S; Demblon C; Jeanbaptiste B; Poelaert D; Stockis A
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):61-70. PubMed ID: 8929748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The antihypertensive effect of the new cardioselective prolonged-action beta-adrenoblocker bisoprolol compared with propranolol, metoprolol and placebo].
    Metelitsa VI; Duda SG; Gorbunov VM; Buchner-Moll D; Deev AD; Vygodin VA; Filatova NP; Chel'dieva EIa; Shastun RS; Simonov DV
    Eksp Klin Farmakol; 1995; 58(2):32-4. PubMed ID: 7773086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK with a conventional slow release preparation.
    Oosterhuis B; Jonkman J; Zuiderwijk P; Sollie F
    J Clin Pharmacol; 1990 Feb; 30(S2):S33-8. PubMed ID: 2312777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between metoprolol plasma concentration and beta 1-blockade in healthy subjects: a study on conventional metoprolol and metoprolol CR/ZOK formulations.
    Abrahamsson B; Lücker P; Olofsson B; Regårdh CG; Sandberg A; Wieselgren I; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S46-54. PubMed ID: 1968913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic evaluation of metoprolol controlled release (CR/ZOK) 50 mg in young subjects.
    Wieselgren I; Lundborg P; Sandberg A; Olofsson B; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S28-32. PubMed ID: 2312776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving optimal beta1-blockade with metoprolol CR/Zok.
    Wikstrand J
    Basic Res Cardiol; 2000; 95 Suppl 1():I46-51. PubMed ID: 11192353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic properties of controlled release (CR/ZOK) metoprolol in healthy Oriental subjects: a comparison with conventional formulations of metoprolol and atenolol.
    Darmansjah I; Wong E; Setiawati A; Moeloek D; Irawati D; Siagian M; Muchtar A
    J Clin Pharmacol; 1990 Feb; 30(S2):S39-45. PubMed ID: 2312778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups.
    Kayser A; Beck E; Hoeltzenbein M; Zinke S; Meister R; Weber-Schoendorfer C; Schaefer C
    J Hypertens; 2020 Feb; 38(2):354-361. PubMed ID: 31584512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM; Rabot D; Herrero G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complex assessment of efficacy and tolerance of metoprolol CR/ZOK in treating hypertension].
    Podzolkov VI; Strizhakov LA; Pavlov VI; Makolkin VI
    Ter Arkh; 2002; 74(11):74-7. PubMed ID: 12498136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of migraine using bisoprolol. Results of a double-blind study versus metoprolol].
    Wörz R; Reinhardt-Benmalek B; Föh M; Grotemeyer KH; Scharafinski HW
    Fortschr Med; 1992 May; 110(14):268-72. PubMed ID: 1351025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.